http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000327565-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af1950f3689c27676cb3a2c543f2c79d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 1999-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_250d376330dc17140d904c59cd1dc92c |
| publicationDate | 2000-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2000327565-A |
| titleOfInvention | Acetylcholinesterase inhibitor |
| abstract | (57) [Problem] To provide an AChE inhibitor which suppresses or alleviates the onset of Alzheimer's disease and the like, with or without side effects. SOLUTION: Ajoene as an active ingredient of an AChE inhibitor inhibits the activity of AChE which has a function of inactivating ACh which is a neurotransmitter. By inhibiting the activity of AChE, diseases such as Alzheimer's disease, which is considered to be caused by excessive decrease or deficiency of ACh, can be suppressed or alleviated. Moreover, compound E -, There are no reports of toxicity or side effects of Z-ajoene. Ajoen is considered harmless to the human body, so there is no risk of side effects even if taken long. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001206843-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4515581-B2 |
| priorityDate | 1999-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.